0RAG.L - ABIONYX Pharma SA

LSE - LSE Delayed price. Currency in EUR
Currency in EUR

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.23
52-week change 3-12.23%
S&P500 52-week change 31.77%
52-week high 32.3600
52-week low 30.0000
50-day moving average 31.9621
200-day moving average 31.9246

Share statistics

Avg vol (3-month) 31.55k
Avg vol (10-day) 3625
Shares outstanding 518.22M
Implied shares outstanding 6N/A
Float 8N/A
% held by insiders 132.36%
% held by institutions 111.95%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)31 Dec 2022

Profitability

Profit margin -79.25%
Operating margin (ttm)-77.36%

Management effectiveness

Return on assets (ttm)N/A
Return on equity (ttm)N/A

Income statement

Revenue (ttm)5.3M
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)312.00%
Gross profit (ttm)700k
EBITDA -4.07M
Net income avi to common (ttm)-4.2M
Diluted EPS (ttm)-0.1480
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)N/A
Total cash per share (mrq)N/A
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)N/A
Book value per share (mrq)0.31

Cash flow statement

Operating cash flow (ttm)-3.4M
Levered free cash flow (ttm)N/A